PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Synairgen’s inhaled COVID-19 treatment included in US trial

Synairgen’s inhaled interferon beta-1a treatment, SNG001, has been selected for inclusion in the US government-funded ACTIV-2 trial in COVID-19 outpatients. The Ph...
Continue Reading →
News

Optibrium Raises Investment to Advance Computer-Aided Drug Discovery

Optibrium™, a developer of software for drug discovery, today announced it has raised significant investment from Kester Capital, a leading UK mid-market private equ...
Continue Reading →
News

Oxford/AstraZeneca COVID-19 vaccine offers limited protection against South African variant

Analysis submitted as a pre-print prior to peer-review publication has shown that a two-dose regimen of the Oxford/AstraZeneca COVID-19 vaccine provides minimal prot...
Continue Reading →
News

World’s first clinical trials of COVID-19 vaccine combination

In a bid to combat future mutations of COVID-19, a joint research programme will begin in February 2021 to assess the immunogenicity and safety of the combined usage...
Continue Reading →
News

Novo Nordisk’s Sogroya moves closer towards EU approval

Novo Nordisk’s Sogroya (somapacitan) has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use – movi...
Continue Reading →
News

Sputnik V COVID-19 vaccine demonstrates 91.6% efficacy

The Lancet has published interim results of a Phase III clinical trial of Sputnik V, confirming the vaccine demonstrated efficacy of 91.6%. Sputnik V, which is based...
Continue Reading →
News

CSafe Global Continues Expansion Across Asia with Two New Hub Locations in China

Through a partnership with C.H. Robinson, CSafe will establish hub operations in Beijing and Guangzhou to support local customers. CSafe Global, the innovation lea...
Continue Reading →
News

Edesa Biotech Receives C$14 million for COVID-19 Study

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has secured a commitment of up to C$14 million (US$ 11 million) from the Government of...
Continue Reading →
News

Bayer to manufacture mRNA vaccine in Germany

In a joint press briefing today together with German Health Minister Jens Spahn, Minister-President of North Rhine-Westphalia, Armin Laschet, and Chief Executive Off...
Continue Reading →
News

MLM announces new executive leadership – Scott Houlton named CEO and Roger Gasper CFO

Moenchengladbach, GERMANY; MEMPHIS, TN; MINNEAPOLIS, MN — MLM Medical Labs (“MLM”) is pleased to announce that Scott Houlton has joined the company as the new Chi...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026